How Long Does It Take for Simponi to Start Working?
Simponi (golimumab) typically begins showing clinical benefits within 4 to 6 weeks of starting treatment, though the exact timing varies by condition and individual patient response. For ulcerative colitis, formal response assessment occurs at 6 weeks, while rheumatoid arthritis patients may notice improvements as early as 4 weeks into treatment.
Shop Medications
Simponi is a TNF blocker that works by targeting specific immune system proteins causing inflammation in autoimmune conditions. Understanding when to expect results helps patients and healthcare providers make informed treatment decisions and avoid premature discontinuation of potentially effective therapy.
In This Article
- What Is Simponi and How Does It Work in the Body?
- How Long Does Simponi Take to Work for Rheumatoid Arthritis?
- When Does Simponi Start Working for Ulcerative Colitis?
- How Quickly Does Simponi Work for Psoriatic Arthritis?
- What Factors Affect How Fast Simponi Starts Working?
- What Should You Expect During Your First Few Weeks on Simponi?
- When Should You Contact Your Doctor About Simponi’s Effectiveness?
- References
What Is Simponi and How Does It Work in the Body?
Simponi (golimumab) is a biologic medication that blocks tumor necrosis factor alpha (TNF-alpha), a protein that causes inflammation in autoimmune diseases. It belongs to a class of medications called TNF inhibitors or anti-TNF drugs, which work by binding to and neutralizing excess TNF-alpha in the immune system.
The medication is administered as a subcutaneous injection, typically given once monthly for most conditions. Simponi is FDA-approved for treating rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis in adults. Each condition involves chronic inflammation that Simponi helps control by reducing the overactive immune response.

Why Pay Full Price?
Search our full medication catalogue and save up to 80% - no insurance needed.
See Prices NowUnlike traditional medications that provide symptom relief within hours or days, biologic medications like Simponi require time to build up in the system and modulate immune function. This is why the onset of action is measured in weeks rather than days.
How Long Does Simponi Take to Work for Rheumatoid Arthritis?
For rheumatoid arthritis, Simponi can begin showing symptom improvement as early as 4 weeks after starting treatment. Clinical studies demonstrate that meaningful responses typically become evident within the first month to 6 weeks of therapy.
In clinical trials, approximately 45% to 51% of patients achieved an ACR20 response (a standard measure of improvement in rheumatoid arthritis) by week 14 of treatment. This response rate was significantly higher than the 9% seen with placebo treatment. The ACR20 response indicates at least 20% improvement in tender and swollen joint counts, plus improvement in three of five additional measures including pain, function, and inflammation markers.
Patients may notice early signs of improvement such as reduced morning stiffness, decreased joint pain, or improved mobility before formal response assessments. However, maximum benefit often continues to develop over several months of consistent treatment.
When Does Simponi Start Working for Ulcerative Colitis?
For ulcerative colitis, Simponi’s effectiveness is formally assessed at 6 weeks during the induction phase of treatment. Clinical studies show that approximately 51% to 58% of patients achieve clinical response by week 6, compared to about 30% of patients receiving placebo.
Clinical response in ulcerative colitis is measured using the Mayo score, which evaluates stool frequency, rectal bleeding, physician assessment, and endoscopic findings. A clinical response indicates meaningful reduction in these symptoms and inflammation markers.
Some patients may begin experiencing symptom relief before the 6-week assessment point. Early signs of improvement might include reduced bowel movement frequency, decreased rectal bleeding, or less abdominal cramping. However, the 6-week timeframe represents when healthcare providers can reliably evaluate whether the medication is providing clinically meaningful benefit.
How Quickly Does Simponi Work for Psoriatic Arthritis?
For psoriatic arthritis, Simponi typically shows clinical benefits within 3 to 4 months of treatment, though some patients may notice improvements sooner. Real-world studies suggest that response rates improve with continued treatment over several months rather than showing immediate effects.
Psoriatic arthritis involves both joint inflammation and skin symptoms, and these may respond at different rates. Joint symptoms such as pain, swelling, and morning stiffness may improve within the first month to 6 weeks. Skin psoriasis symptoms may take longer to show significant improvement, sometimes requiring 3 to 4 months of consistent treatment.
Healthcare providers typically assess psoriatic arthritis response using measures that evaluate both joint and skin involvement. Patients should maintain realistic expectations, as maximum benefit often develops gradually over the first several months of therapy.
What Factors Affect How Fast Simponi Starts Working?
Several factors influence how quickly Simponi begins working, including disease severity, previous treatment history, and individual immune system response. Patients with more severe disease activity may take longer to show improvement, while those with milder symptoms might notice benefits sooner.
Previous biologic treatment can affect response timing. Patients who are biologic-naive (never used TNF inhibitors before) may respond more quickly than those switching from other biologics. Additionally, concurrent medications like methotrexate in rheumatoid arthritis can enhance and accelerate Simponi’s effectiveness.
Individual patient factors such as age, overall health status, and genetic variations in drug metabolism also play a role. Some patients naturally process medications differently, leading to faster or slower onset of action. Body weight and injection technique can also influence how quickly the medication reaches therapeutic levels.
What Should You Expect During Your First Few Weeks on Simponi?
During the first few weeks of Simponi treatment, patients should focus on monitoring for both improvements and potential side effects rather than expecting dramatic changes immediately. Most people will not notice significant symptom relief in the first 1 to 2 weeks, as the medication needs time to build up in the system.
Keep a symptom diary tracking pain levels, joint stiffness, bowel symptoms (for ulcerative colitis), or other relevant measures. This helps you and your healthcare provider objectively assess whether the medication is working. Many patients report gradual improvements that become more noticeable over time rather than sudden dramatic changes.
Common side effects during the initial weeks may include injection site reactions such as redness, swelling, or mild pain where the shot was given. These reactions typically decrease with continued use as the body adjusts to the medication.
When Should You Contact Your Doctor About Simponi’s Effectiveness?
Contact your healthcare provider if you experience no improvement in symptoms after 3 to 4 months of consistent Simponi treatment, as this may indicate the need for dose adjustment or alternative therapy. Most patients show some response by this timeframe if the medication is going to be effective for them.
Also reach out if your symptoms worsen significantly during the first few months of treatment, especially if you develop new symptoms or increased disease activity. This could indicate that Simponi is not the right medication for your condition or that additional treatments are needed.
Schedule regular follow-up appointments as recommended by your healthcare provider, typically every 3 to 6 months initially. These visits allow for objective assessment of treatment response using standardized measures and monitoring for potential side effects through blood tests and physical examination.
Never stop Simponi abruptly without consulting your healthcare provider, even if you feel the medication is not working quickly enough. Sudden discontinuation can lead to disease flares, and your doctor may recommend adjusting the treatment approach rather than stopping entirely.
References
- Simponi (golimumab) [Prescribing Information]. Janssen Biotech, Inc. Last updated 10/2025. Accessed September 29, 2026.
- Simsek I, Yazici Y. Safety and clinical efficacy of golimumab in the treatment of arthritides. Drug Healthc Patient Saf. 2010;2:169-80. doi: 10.2147/DHPS.S6187. Accessed September 29, 2026.
- Krüger K, Burmester GR, Wassenberg S, Thomas MH. Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany. Rheumatol Ther. 2020 Jun;7(2):371-382. doi: 10.1007/s40744-020-00204-9. Accessed September 29, 2026.si